Angeion Corp. (ANGN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Angeion Corp. (ANGN)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
1046	3	0	ANGN

Emcee: Todd Rozelle	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
46	I guess its up to the lawyers now. Maybe thats good. Management sure hasn't	Edward A. Fitzpatrick III	-	11/20/1996
45	SEE BELOW 2 NEWS REPORTS TODAY!!!! ANY COMMENTS???????? #1 ARBITRATION A	Tmanquinn	-	11/20/1996
44	Anyone still following this one? Heard any news? Rumors? Will they come back al	Edward A. Fitzpatrick III	-	11/18/1996
43	I bought the April 97 calls (7.50 strike). I just received a copy of the Oct.	Mark Cahill	-	10/30/1996
42	Mark: What are your thoughts (Buy,Sell or Hold) on ANGN going forward? Has ever	Edward A. Fitzpatrick III	-	10/30/1996
41	To All: Teleconference at 9:30 CST (719) 386-9006. Sorry for the short notice	Edward A. Fitzpatrick III	-	10/25/1996
40	A conference call betweem Angeion officers and investors and analysts is being	Mark Cahill	-	10/24/1996
39	Following the sale of Angeion's OEM and cardiovascular accessories business	Mark Cahill	-	10/24/1996
38	Mark, You are correct. The MADIT study did not refer to any FDA statements. I	Frank	-	10/24/1996
37	Mark: Given ANGN's small capitalization and their strong patent portfolio,	Edward A. Fitzpatrick III	-	10/24/1996
36	The research document issued from Nat West gives an excellent description of th	Mark Cahill	-	10/24/1996
35	Angeion downplayed the effect of the St. Jude/Ventritex merger in a press relea	Don C.	-	10/24/1996
34	Frank: Thanks for the information on the FDA processes. I am currently watchin	Edward A. Fitzpatrick III	-	10/23/1996
33	Edward, My answer may be a moot point with the St. Jude announcement, but I	Frank	-	10/23/1996
32	Slow death, I'm afraid. Damn.	Edward A. Fitzpatrick III	-	10/23/1996
31	To All: Just heard on that St. Jude will acquire Ventritex. What does this me	Don C.	-	10/23/1996
30	Edward, There was a Reuter's news story this morning on the Senti	Dale Schafer	-	10/21/1996
29	Frank, How is the FDA favoring GDT? Or more specifically, what is the nature of	Edward A. Fitzpatrick III	-	10/21/1996
28	Mark and Edward, I just started reading a book called, Developing products in H	Frank	-	10/21/1996
27	ANGN up to 6 from 5.5 earlier this morning.This is more intra day volatility th	Edward A. Fitzpatrick III	-	10/21/1996
26	I agree with both of you. ANGN is not going to replace any of the three big pla	Edward A. Fitzpatrick III	-	10/18/1996
25	I agree that ANGN is, now, not a threat to the three major players. Indeed, th	Mark Cahill	-	10/18/1996
24	Mark, I reviewed some previous comments you made relative the feature set asso	Frank	-	10/16/1996
23	NatWest report states "Due to investor anxiety regarding the outlook for i	Mark Cahill	-	10/15/1996
22	Mark, ANGN down 8% today. What's up with That?? Am I missing something her	Edward A. Fitzpatrick III	-	10/11/1996

Go to reply# or date (mm/dd/yy):